CDKN2A and central nervous system cancer: 1p/19q-codeleted gliomas generally lack alterations in genes associated with oncogene-induced senescence such as BRAF or senescence bypass such as TP53, RB1 or CDKN2A. Nevertheless, given their continued clinical growth it appears that these tumors have somehow evaded growth arrest and senescence barriers.